跳至主要内容
临床试验/CTRI/2021/11/038018
CTRI/2021/11/038018进行中(未招募)未知

A Prospective Randomized Controlled Study To Analyze The Effects Of Denosumab On Bone Mineral Density And Bone Metabolism Indices In Renal Allograft Transplant Patients.

PGIMER Chandigarh0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
进行中(未招募)

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • All patients 18 years and above undergoing renal allograft transplant in the Department of Renal Transplant Surgery, PGIMER Chandigarh.

排除标准

  • Allograft dysfunction: Serum creatinine value above 2.5mg/dl at three weeks post transplantation.
  • Patient with severe hyperparathyroidism or hypoparathyroidism (iPTH >800 or <10ng/L) prior to transplant.
  • Patients with severe hypocalcaemia or hypercalcemia (total calcium <7.2 or > 11mg/dl) prior to transplant.
  • If subject failed to lay supine position during DEXA scan.

研究者

相似试验